Agena Bioscience and Heartgenetics Announce Co-Marketing Alliance

HEARTDECODE® Software and Assays Designed for Use with the MassARRAY® DX System San Diego, CA, July 18, 2017– Agena Bioscience today announced a co-promotion agreement leveraging its MassARRAY® DX clinical diagnostics technology with HeartGenetics’ CE-IVD marked products for cardiovascular testing. The MassARRAY DX, a CE-IVD marked system, provides a streamlined... Read More

Agena Bioscience Announces Expanded Partnership With Assurex Health

MassARRAY® System Selected for Assurex Health’s GeneSight Test SAN DIEGO, Calif., June 20, 2017– Agena Bioscience today announced that Assurex Heath, a wholly owned subsidiary of Myriad Genetics, Inc., has selected the MassARRAY® System for streamlined laboratory set-up and sample processing of Assurex Health’s GeneSight test. The GeneSight Psychotropic test... Read More